IRIS
FELICIONI, LARA BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 831
EU - Europa 760
AS - Asia 427
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 825
CN - Cina 161
SG - Singapore 144
UA - Ucraina 136
GB - Regno Unito 124
IE - Irlanda 117
SE - Svezia 102
IT - Italia 85
FR - Francia 82
TR - Turchia 75
DE - Germania 47
IN - India 32
FI - Finlandia 25
RU - Federazione Russa 25
BE - Belgio 6
CA - Canada 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
JP - Giappone 3
VN - Vietnam 3
CL - Cile 2
CO - Colombia 2
EU - Europa 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
LT - Lituania 1
MN - Mongolia 1
RS - Serbia 1
Totale 2.026
Salva come PNG Salva come JPEG
Città #
Chandler 204
Jacksonville 153
Singapore 129
Dublin 117
Southend 70
Princeton 58
Beijing 52
Izmir 52
Nanjing 47
Altamura 30
Ashburn 29
Ann Arbor 26
Cambridge 25
Wilmington 23
Boardman 21
Santa Clara 19
Dearborn 14
Nanchang 14
Tianjin 9
Kunming 8
Hebei 7
Woodbridge 7
Augusta 6
Brussels 6
Collecorvino 6
Los Angeles 6
Washington 6
Grevenbroich 5
Jinan 5
Brno 4
Jiaxing 4
Pescara 4
Shenyang 4
Verona 4
Dong Ket 3
Falls Church 3
Gloucester 3
Hangzhou 3
Helsinki 3
Milan 3
Munich 3
Ottawa 3
Rome 3
San Mateo 3
Taichung 3
Toronto 3
Auburn Hills 2
Cavacurta 2
Changsha 2
Chieti 2
Civitanova Marche 2
Hanover 2
New Delhi 2
New York 2
Olomouc 2
Oslo 2
Santa Marta 2
Watertown 2
Zhengzhou 2
Andover 1
Aquila 1
Auckland 1
Basking Ridge 1
Belgrade 1
Clearwater 1
Concordia Sagittaria 1
Council Bluffs 1
Eden Prairie 1
Fairfield 1
Frankfurt am Main 1
Iowa City 1
Kobe 1
Lanzhou 1
Las Vegas 1
Laurel 1
Leawood 1
Miami 1
Newcastle-under-Lyme 1
Ningbo 1
Norwalk 1
Nuremberg 1
Orange 1
Palermo 1
Paris 1
Romola 1
Saint Louis 1
San Vito Chietino 1
Serio 1
Spoltore 1
Tappahannock 1
Tauranga 1
Tokyo 1
Ulan Bator 1
Varallo 1
Walnut 1
Wayne 1
Totale 1.273
Salva come PNG Salva come JPEG
Nome #
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 133
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer 98
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 95
Assessing EGFR mutations. 90
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. 84
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 82
AKT1(E17K) in human solid tumours 82
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 81
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation 81
Mutational profile of GNAQQ209 in human tumors. 79
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 78
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 74
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 73
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 73
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 72
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 71
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 70
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 70
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 68
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 67
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 66
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 65
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 65
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 64
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 61
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 61
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 61
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: A study of the Italian NGS Network 21
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 12
Totale 2.097
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 14 17 11 32 24 8 63 47 8
2020/2021170 26 7 34 0 16 34 4 2 13 23 0 11
2021/2022163 5 2 1 28 8 12 4 18 15 14 16 40
2022/2023511 37 81 29 67 55 94 20 31 73 3 11 10
2023/2024212 19 4 17 7 17 47 45 6 1 16 2 31
2024/2025250 32 107 100 11 0 0 0 0 0 0 0 0
Totale 2.097